Colorectal Cancer Screening

eCQM / NQF #: CMS130v7 / 0034
Measure: Percentage of adults 50-75 years of age who had appropriate screening for colorectal cancer.
Numerator: Patients with one or more screenings for colorectal cancer. Appropriate screenings are defined by any one of the following criteria: - Fecal occult blood test (FOBT) during the measurement period - Flexible sigmoidoscopy during the measurement period or the four years prior to the measurement period - Colonoscopy during the measurement period or the nine years prior to the measurement period - FIT-DNA during the measurement period or the two years prior to the measurement period - CT Colonography during the measurement period or the four years prior to the measurement period.
Denominator: Patients 50-75 years of age with a visit during the measurement period.
Denominator Exclusions: Patients with a diagnosis or past history of total colectomy or colorectal cancer. Exclude patients who were in hospice care during the measurement year.
Domain: Effective Clinical Care

 

In ChartMaker Clinical:

In order to qualify for this measure, the provider must have seen the patient (age 50-75) at least one time during the reporting period and have the appropriate information documented in the chart:

Required Data Elements for the Denominator:

Required Data Elements for the Numerator:

At least one of the following:  

EXCLUSION DETAILS:

Exclusion includes patients with a diagnosis or past history of Total Colectomy or Colorectal Cancer OR who were in hospice care during the measurement period.  In order to meet the requirement for this exclusion, the appropriate information must be documented in the chart (at least one of the following):

ADDITIONAL INFORMATION:

•   The patient must be at least 50 years and up to 75 years of age prior to the start of the measurement period.

•  The Fecal Occult Blood Test (FOBT) and FIT DNA LOINC code can be linked to the applicable result from an electronic interface or from a numeric field in the chart note. Either item must be configured as a result in it's properties.

•   The exclusion diagnosis of Malignant Neoplasm of the Colon can be a status of resolved, inactive or active prior to or during the reporting period to count in the exclusion.

•   The only data used to determine the denominator is data from the ChartMaker Clinical Module. If a patient encounter was not entered into the ChartMaker Clinical Module, that encounter is not included in the denominator for the statistical calculations on the Meaningful Use Dashboard. Please add these additional patients to the denominator and recalculate the percentage for Attestation purposes.